December 27, 2024 - 20:05

If you've accumulated a significant nest egg with a financial services firm, you may have encountered offers for financial advice — typically for a fee. The question many investors face is whether utilizing these advisers is truly beneficial.
Financial advisers can provide valuable insights, helping clients navigate complex investment landscapes, tax strategies, and retirement planning. They often have access to exclusive investment opportunities and can tailor strategies to align with individual financial goals. However, these services usually come at a cost, which can eat into your overall returns.
Before deciding to engage with your firm's advisers, consider your financial knowledge and comfort level. If you feel confident managing your investments, you might opt to handle your portfolio independently. Conversely, if the intricacies of financial planning feel overwhelming, seeking professional guidance could prove advantageous. Ultimately, the decision should align with your financial objectives and personal preferences, weighing the potential benefits against the associated costs.
June 7, 2026 - 04:43
Why Pay More for Gold? GLDM Offers the Same Bullion for a Fraction of GLD's CostA 58-year-old investor with $100,000 parked in SPDR Gold Trust (GLD) as a crisis hedge is paying roughly $300 more per year than necessary for the exact same bars of bullion. That is the...
June 6, 2026 - 00:01
The Spill: Why Financial Pros Are Piling Into IWM Right NowAfter years of playing second fiddle to mega-cap tech stocks, small-cap equities are suddenly the center of attention. The iShares Russell 2000 ETF, known by its ticker IWM, is seeing a wave of...
June 5, 2026 - 04:07
Medallion Financial Corp. Exposes ZimCal’s Latest Campaign of Distortion and the Risks of Electing Its Unqualified NomineesMedallion Financial Corp. has issued a sharp rebuttal against ZimCal`s latest proxy fight, accusing the investment firm of running a campaign built on distortions and misaligned incentives. The...
June 4, 2026 - 04:31
OSE Immunotherapeutics Reports Full Year 2025 Audited Consolidated Financial Results and Announces the Filing of its 2025 Universal Registration DocumentOSE Immunotherapeutics SA announced its audited consolidated financial results for the full year 2025 on June 3, 2026. The company confirmed that the audited figures are consistent with the...